Polyphenols from Arctium lappa L ameliorate doxorubicin‐induced heart failure and improve gut microbiota composition in mice.

Autor: Wu, Xiaonan, Zhang, Nianfeng, Kan, Juan, Tang, Sixue, Sun, Rui, Wang, Zhihao, Chen, Mengfei, Liu, Jun, Jin, Changhai
Předmět:
Zdroj: Journal of Food Biochemistry; Mar2022, Vol. 46 Issue 3, p1-17, 17p
Abstrakt: In this study, the ameliorative effect of purified polyphenols from Arctium lappa L (ALPP) on doxorubicin (DOX)‐induce heart failure was investigated. Results indicated that ALPP pretreatment significantly reduced the activities of casein kinase and lactate dehydrogenase, lowered the levels of inflammatory indexes (TNF‐α and NO), and alleviated antioxidant stress in DOX‐induce mice, thus leading to a reduced heart failure syndrome. In addition, according to 16s high‐throughput sequencing, the increased abundance of Lactobacillaceae,Muribaculaceae, and Ruminococcaceae and the decreased abundance of Proteobacteria,Enterobacteriaee, and Escherichia_Shigella were observed in ALPP treatment group. ALPP could significantly enhance the abundance of bacteria producing short chain fatty acids (SCFAs) and then promote the increase of SCFAs. Consequently, ALPP might be a therapeutic alternative in the treatment of DOX‐induced heart failure. Practical applications: The effect of Arctium lappa L (ALPP) on doxorubicin (DOX)‐induced heart failure was investigated. It provided experimental basis for further studies on the biological activity of polyphenols from ALPP. The results demonstrated that ALPP could significantly ameliorate DOX‐induced heart failure and improve the gut microbiota composition. The obtained results could provide the potential application of ALPP as an alternative therapy for heart failure in the functional food industry. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Nepřihlášeným uživatelům se plný text nezobrazuje